IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q1 2025 Holdings

Filed 2025-05-14 | 11 holdings | $73.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$45.8M5,664,54862.7%
TG Therapeutics Inc(TGTX)COM88322Q108$6.4M161,6008.7%
Invivyd Inc(IVVD)COM00534A102$5.6M9,248,2507.7%
Bridgebio Pharma Inc(BBIO)COM10806X102$4.2M121,2005.7%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$2.6M385,6803.5%
Springworks Therapeutics IncCOM85205L107$2.4M55,2003.3%
Fractyl Health Inc(GUTS)COM35168W103$2.2M1,856,1173.0%
Proqr Thrapeutics N VSHS EURON71542109$1.4M1,019,4981.9%
Curis Inc(CRIS)COM231269309$1.1M521,0591.5%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$858.7K67,4001.2%
Silence Therapeutics PLC(SLN)ADS82686Q101$522.0K185,1000.7%